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Abstract Previous studies have suggested that asthma,
like other common diseases, has at least part of its origin
early in life. Low birth weight has been shown to be asso-
ciated with increased risks of asthma, chronic obstructive
airway disease, and impaired lung function in adults, and
increased risks of respiratory symptoms in early childhood.
The developmental plasticity hypothesis suggests that the
associations between low birth weight and diseases in later
life are explained by adaptation mechanisms in fetal life and
infancy in response to various adverse exposures. Various
pathways leading from adverse fetal and infant exposures to
growth adaptations and respiratory health outcomes have
been studied, including fetal and early infant growth pat-
terns, maternal smoking and diet, children’s diet, respira-
tory tract infections and acetaminophen use, and genetic
susceptibility. Still, the speciﬁc adverse exposures in fetal
and early postnatal life leading to respiratory disease in
adult life are not yet fully understood. Current studies
suggest that both environmental and genetic factors in
various periods of life, and their epigenetic mechanisms
may underlie the complex associations of low birth weight
with respiratory disease in later life. New well-designed
epidemiological studies are needed to identify the speciﬁc
underlying mechanisms. This review is focused on speciﬁc
adverse fetal and infant growth patterns and exposures,
genetic susceptibility, possible respiratory adaptations and
perspectives for new studies.
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Asthma in childhood has a high prevalence across many
countries worldwide [1]. The reported prevalence of asthma
is around 5–10% among school-age children and ﬁgures are
evenhigherforasthmarelated symptoms, suchaswheezing,
inyoungerchildren.Childhoodasthmaisrelatedtoareduced
quality of life and exercise tolerance, and higher risks of
school absenteeism and hospitalization [2]. Despite the
availability of effective treatments for symptoms, the mor-
bidityremainshigh[3].Thelackofcurativeoptionsseemsto
be largely due to the unknown aetiology of asthma [4].
Furthermore, one general deﬁnition of asthma is difﬁcult to
deﬁne[5].Objectivetests,includingspirometryorbronchial
hyperresponsiveness, are not easy to conduct in young
children, and have limited applicability. In epidemiological
studiesitiscurrentlywellacceptedthatadiagnosisofasthma
isbasedonparental-orself-reportedsymptoms[6].Because
of these different asthma deﬁnitions, it is important to
identify the speciﬁc underlying mechanisms for the associ-
ations of exposures in fetal life and infancy with different
asthma related outcomes, which might reﬂect different
speciﬁc structural and functional adaptations.
Several studies, of which some have been published in
the European Journal of Epidemiology have suggested that
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origin early in life [4, 7–41]. Long term follow up studies
in different populations have shown that impaired respi-
ratory health or lung function in early childhood is asso-
ciated with asthma and other respiratory diseases in later
life [42–48]. These studies suggest that lung function and
susceptibility for various respiratory diseases track from
early childhood onwards. Thus, risk factors for wheezing
and asthma or low airway function in childhood might
predispose for respiratory diseases in later life. Examples
of known major risk factors in early childhood for devel-
opment of respiratory disease or low airway function
include exposure to parental smoking or air pollution, no or
shorter period of breastfeeding, obesity, larger family size,
daycare attendance, infectious diseases in early childhood
and acetaminophen use [49–56].
Developmental origins of childhood asthma
Recently, low birth weight has also been shown to be
associated with increased risks of asthma, chronic
obstructive airway disease, and impaired lung function in
adults [57–61]. In term born children, it was found that low
birth weight is associated with increased risks of respira-
tory symptoms in the ﬁrst 7 years of life [62]. Low birth
weight per se is not likely to be the causal factor leading to
asthma. The same birth weight might be the result of
various growth patterns and different fetal exposures [10,
63]. The developmental plasticity hypothesis suggests that
the associations between low birth weight and diseases in
later life are explained by early adaptation mechanisms in
response to various adverse exposures in fetal life and early
childhood [64]. This hypothesis is supported by extensive
epidemiological evidence showing strong and consistent
associations of low birth weight with the risk of common
diseases in adulthood, including cardiovascular disease,
type 2 diabetes and COPD [10, 64–66]. Developmental
adaptations in fetal life and infancy might also result in
impaired lung growth, leading to smaller airways,
decreased lung volume, and subsequently to an increased
risk of asthma or COPD throughout postnatal life [46, 58,
60, 66, 67]. Reduced diameter of central and small airways
can contribute to the development of childhood asthma
[68–70]. Airway caliber is a key determinant of total
airway resistance and might be related to asthma and
COPD [71]. Other mechanisms underlying the associations
of low birth weight with asthma and respiratory diseases in
childhood and adulthood might include an innate or T
helper 2 skewed immune system, increased allergen
sensitization, inﬂammation and bronchial hyperreactivity
[72–75]. These different underlying mechanisms may lead
tovarious phenotypes ofasthma with onset atdifferent ages.
Fetal growth characteristics
Studies with information about fetal growth characteristics
in different periods of pregnancy enable identiﬁcation of
critical fetal periods that might be important for the risk of
asthma and other respiratory diseases [76, 77]. A recent
study suggested no associations of fetal growth character-
istics with the risk of ‘ever wheeze’ until the age of 3 years
[78]. However, when the outcome wheeze was combined
with atopic status of the child, the authors showed that a
SD lower fetal head circumference growth between 11 and
19 weeks was associated with a 10% higher risk of non-
atopic wheeze, and a SD lower fetal abdominal circum-
ference growth between 19 and 34 weeks of gestation was
associated with a 20% higher risk of atopic wheezing.
Another study with retrospectively collected fetal mea-
surements observed that reduced fetal size in ﬁrst trimester
is associated with increased risks for asthma and airway
obstruction in children aged 10 years [79]. This study did
not take postnatal growth parameters into account. How-
ever, infant weight gain, which is generally higher in
children with a low birth weight, is also associated with
respiratory morbidity in childhood [78, 80]. Recently, a
prospective population-based cohort study among 5,125
children observed that not fetal growth, but weight gain
acceleration in early infancy was associated with increased
risks of asthma symptoms in preschool children, indepen-
dent of fetal growth [81]. These results suggest that early
infancy might be a more critical period for the develop-
ment of asthma. The associations of longitudinally mea-
sured fetal and early childhood growth patterns with
various phenotypes of asthma, lung function and lung
structure in childhood and later life adjusted for potential
confounders remain to be studied in further detail.
In addition to fetal and early childhood growth, preterm
birth is suggested to be associated with asthma and
impaired lung function [81–88]. A recent meta-analysis
showed that preterm birth deﬁned as a gestational age less
than 37 weeks at birth was associated with an 1.07–1.36
increased risk of asthma, depending on the heterogeneity of
the studies, compared with children born at term [82]. This
effect seemed stronger at a younger age but this difference
might reﬂect differences between study populations rather
than a real age effect. Potential underlying pathways for the
association between preterm birth and asthma are not dis-
entangled yet but might include underdeveloped anatomi-
cal or immunological mechanisms [89, 90], interaction
with environmental factors, such as smoke exposure and
chorioamnionitis [49, 84], or genetic factors [91]. Also, the
degree of immaturity, therapeutic interventions and co-
morbidity might play a role. Recent studies observed
inconsistent results on the associations of gestational age
and risks of asthma for children born late preterm [85, 87,
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12388] and children born early preterm with or without
mechanical ventilation [88] or bronchopulmonary dyspla-
sia [86, 92]. Future studies are needed to elaborate on these
aspects.
Maternal smoking and diet
Maternal smoking is the most important adverse fetal
exposure in Western countries, and is strongly associated
with fetal growth retardation and low birth weight [63].
Recent studies have demonstrated that maternal smoking
during pregnancy is associated with increased risks of
wheezing and asthma during childhood [93–99]. Most
studies were not able to assess the effect of maternal
smoking exposure in different periods of pregnancy, which
might be important for identifying critical periods. It is also
not known whether the associations between maternal
smoking during pregnancy and the risk of childhood
asthma are explained by direct intrauterine effects, or
reﬂect other unmeasured environmental confounders.
Stronger effect estimates for maternal smoking than for
paternal smoking during pregnancy with childhood asthma
would suggest direct intra-uterine effects, whereas similar
effect estimates suggest that the associations are explained
by unmeasured socio-economic, or life style related factors
[100, 101]. Also, as in all observational designs, residual
confounding might still be an issue due to unmeasured
social and life style related factors. This needs to be
explored in detail. Recently, we have demonstrated that
continued maternal smoking throughout pregnancy is
associated with asthma symptoms, including wheezing, in
preschool children [49]. These associations were indepen-
dent of paternal smoking and imply a direct adverse effect
of smoke exposure on fetal lung development. The mech-
anisms by which maternal smoking during pregnancy
affect body and lung growth are not fully understood, but
may include direct toxic effects on the respiratory system
and DNA methylation of genes. Recent studies showed
general and biological pathway speciﬁc differences in
DNA methylation patterns in children from mothers who
smoked during pregnancy [102, 103]. Differences in DNA-
methylation within the promoter regions of particular genes
may alter the expression of the gene products related to
growth and lung development. However, it is not known
whether the associations between low birth weight and
respiratory disease can be fully explained by fetal smoke
exposure, and the related changes in DNA methylation.
Suboptimal fetal nutrition, due to maternal obesity or
underweight, insufﬁcient dietary intake, or placental dys-
function might also affect fetal growth and lung develop-
ment [52, 104–107]. Maternal obesity and placenta
dysfunction are strongly related to fetal growth, but their
direct associations with respiratory health in the offspring
are not fully understood yet [10, 108]. Insufﬁcient maternal
dietary intake of macronutrients during pregnancy may
lead to impaired fetal body, lung and airway growth and
subsequently to an increased risk of asthma in childhood
[104, 109–116]. More speciﬁcally, maternal Mediterranean
and Western dietary patterns during pregnancy are related
to fetal growth patterns [117, 118]. Thus far, little is known
whether these maternal dietary patterns also affect the risk
of childhood asthma [119]. The mechanisms by which
dietary patterns affect body and lung growth development
may also include DNA methylation [120, 121]. Lower
intake of micronutrients such as folate, and vitamin B12 in
mother’s diet may induce epigenetic changes, since folate
and vitamin B12 are important methyl donors during
pregnancy [122]. Vitamin E has the potential to inﬂuence
airway development via epigenetic mechanisms because it
inﬂuences gene expression and airway epithelial cell sig-
nalling [112]. The role of epigenetic mechanisms regarding
the association of low maternal vitamin D intake during
pregnancy with a higher incidence of asthma and wheeze in
children is not known yet [123–127]. The importance of the
maternal intake of these micronutrients on respiratory
health in childhood and adulthood might differ between
developing and Western countries, since the nutritional
status of mothers and children in these countries are
different.
Exposures in infancy
After birth, infant diet may also inﬂuence body and lung
growth development [128]. Speciﬁc infant feeding patterns
such as early introduction of bottle feeding or solid food
instead of a long period of exclusive breastfeeding may
lead to reduced lung and airway growth and increased risk
of childhood asthma [50, 129–132]. Underlying mecha-
nisms that have been suggested to explain the associations
of shorter duration or smaller amount of breastfeeding with
the risks of asthma are breast milk components, including
IgA, cytokines, glycans and long-chain fatty acids that
stimulate and balance the infant’s innate immune system
and growth [133–135]. Atopic and infectious mechanisms
might partly mediate the protective effect of breastfeeding
on childhood asthma [50, 131, 136, 137]. Thus far, previ-
ous studies did report inconsistent results on effect modi-
ﬁcation by family history of asthma, allergy and atopy on
the association of breastfeeding with wheezing [131, 136–
139]. Also, the protective effect of a longer period of
breastfeeding duration on childhood asthma still remains
when respiratory tract infections are taken into account
[50]. Further studies are needed to explore in detail the role
of atopy, infections, suboptimal lung growth [128],
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123epigenetic changes [140] and other possible underlying
mechanisms in the associations between breastfeeding and
asthma.
In the ﬁrst years, childhood asthma symptoms or
wheezing are predominantly related to respiratory tract
infections [53, 55, 56, 141, 142]. Respiratory infectious
diseases in infancy also predict the risk of asthma and other
respiratory diseases in childhood and adulthood [66, 143,
144]. Results from the COPSAC study have shown that
colonization of the airways with S. pneumoniae, H. inﬂu-
enzae, M. catarrhalis, or more than one of these organisms
in asymptomatic neonates at 1 month of age was associated
with increased risks of wheezing symptoms, higher blood
eosinophil counts and total IgE, and development of
asthma in school age children [56]. Similarly, nasal car-
riage with S. aureus is associated with an increased risk of
atopic dermatitis [145]. Still, whether these associations
reﬂect causal mechanisms or reﬂect symptoms of the same
underlying susceptible lung or skin is not known. Acet-
aminophen is frequently used in children with fever epi-
sodes, including those with upper and lower respiratory
tract infections. Several studies have suggested associa-
tions between acetaminophen in childhood and the risk of
asthma [54, 146–150]. A recent review summarized the
existing evidence for the associations of acetaminophen
use with childhood asthma, and suggested that this asso-
ciation might be causal based on various epidemiological
ﬁndings including the strength, consistency, and dose–
response relationship [151]. Also, the metabolism of acet-
aminophen leads to a depletion in airway mucosal gluta-
thione that could contribute to vulnerability to oxidant
stress. Prospective studies relating infectious diseases and
acetaminophen use with different respiratory health out-
comes in adulthood have not been performed yet.
Genetic susceptibility
The associations of low birth weight with respiratory
symptoms in later life might also be explained by common
genetic variants leading to both fetal growth restriction and
smaller lungs and airways and, subsequently, to asthma.
Previous candidate gene studies and linkage studies iden-
tiﬁed more than 100 genes associated with asthma [152,
153]. However, most of these associations could not be
replicated. More recent genome wide approaches in large
study populations successfully identiﬁed and replicated
genetic variants related to asthma in children [154–160].
Variants in the ORM1-like 3 (ORMDL3) gene and in
neighbouring genes, such as gasdermin A and B (GSDM),
have consistently been associated with risk of childhood
asthma. None of the identiﬁed common genetic variants
related to asthma or COPD were associated with birth
weight on a genome wide signiﬁcant level [161], but this
might be due to lack of power. Thus far, no genome wide
association studies have been performed on lung function
in early childhood. Therefore, further studies are needed
that relate genetic variants to both early body and lung
growth characteristics and respiratory diseases in later life.
The effects of early life exposures such as maternal
smoking and diet, breastfeeding and infant infectious dis-
eases on the risk of asthma and COPD might be modiﬁed
by a genetic susceptibility. Recent studies suggest that the
effects of some genetic variants related to asthma, located
on glutathione S-transferase (GST), methylenetetrahydrof-
olate reductase (MTHFR), gasdermin-like (GSDML) and
ORMDL3 genes, are modiﬁed by environmental exposures,
including tobacco smoke exposure [116, 162–167]. The
increased risk of early-onset asthma due to 17q21 genetic
variants of ORDML3, GSDML and 2 other genes was
further enhanced by early childhood tobacco smoke
exposure [162, 164]. Also, GST genes in combination with
fetal smoke exposure seem to be associated with lower
airway responsiveness, lung function and increased risk of
transient wheezing, a phenotype of childhood asthma [163,
166]. However, results for effect modiﬁcation by maternal
smoking on the associations of GST genes with respiratory
morbidity are not consistent [167, 168]. Further gene-
environment studies are needed, especially focused on the
environmental exposures in the fetal period, during which
period alveolar and airway development is largely
completed.
Conclusion
Asthma in childhood is a heterogeneous disease and the
exact underlying origins remain partly unknown. Several
lines of investigation suggest that asthma has at least part
of its origin in fetal life and infancy. Low birth weight
seems to be associated with the risk of childhood asthma,
but may not be the causal factor per se. Therefore, focus for
further research should be beyond birth to identify speciﬁc
fetal and infant growth patterns, their speciﬁc exposures
and gene-environment interactions leading to asthma and
other respiratory diseases in later life (Fig. 1). Speciﬁc
early exposures of interest include maternal smoking and
diet, infant feeding, and infectious diseases in early life.
Developmental adaptation mechanisms in early life that
need to be studied in epidemiological study designs include
DNA methylation, and detailed imaging and functional
assessments of the airways and lungs. Newly identiﬁed
contributing factors to the origins of respiratory diseases
including childhood asthma can ultimately contribute to the
development of novel preventive, diagnostic and thera-
peutic approaches.
8 L. Duijts
123Acknowledgments Dr. Liesbeth Duijts received funding by means
of a European Respiratory Society/Marie Curie Joint Research
Fellowship (nr. MC 1226-2009) under grant agreement RESPIRE,
PCOFUND-GA-2008-229571 and from the seventh framework pro-
gramme, project CHICOS (HEALTH-F2-2009-241504).
Conﬂict of interest The author has no conﬂict of interest.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, dis-
tribution, and reproduction in any medium, provided the original
author(s) and the source are credited.
References
1. Asher MI, Montefort S, Bjorksten B, Lai CK, Strachan DP,
Weiland SK, et al. Worldwide time trends in the prevalence of
symptoms of asthma, allergic rhinoconjunctivitis, and eczema in
childhood: ISAAC phases one and three repeat multicountry
cross-sectional surveys. Lancet. 2006;368(9537):733–43.
2. Masoli M, Fabian D, Holt S, Beasley R. The global burden of
asthma: executive summary of the GINA Dissemination Com-
mittee report. Allergy. 2004;59(5):469–78.
3. Peters SP, Jones CA, Haselkorn T, Mink DR, Valacer DJ, Weiss
ST. Real-world evaluation of asthma control and treatment
(REACT): ﬁndings from a national web-based survey. J Allergy
Clin Immunol. 2007;119(6):1454–61.
4. Behrens T. Current trends in aetiological asthma research. Eur J
Epidemiol. 2009;24(3):115–8.
5. Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA,
Busse WW, et al. An ofﬁcial American Thoracic Society/Euro-
pean Respiratory Society statement: asthma control and exacer-
bations: standardizing endpoints for clinical asthma trials and
clinicalpractice.AmJRespirCritCareMed.2009;180(1):59–99.
6. Edwards CA, Osman LM, Godden DJ, Douglas JG. Wheezy
bronchitis in childhood: a distinct clinical entity with lifelong
signiﬁcance? Chest. 2003;124(1):18–24.
7. Hepworth SJ, Law GR, Lawlor DA, McKinney PA. Early life
patterns of common infection: a latent class analysis. Eur J
Epidemiol. 2010;25(12):875–83.
8. Liu G, Zhu H, Dong Y, Podolsky RH, Treiber FA, Snieder H.
Inﬂuence of common variants in FTO and near INSIG2 and
MC4R on growth curves for adiposity in African- and European-
American youth. Eur J Epidemiol. 2011;26(6):463–73.
9. Slachtova H, Gehring U, Hoek G, Tomaskova H, Luttmann-
Gibson H, Moshammer H, et al. Parental education and lung
function of children in the PATY study. Eur J Epidemiol.
2011;26(1):45–54.
10. Geelhoed JJ, Jaddoe VW. Early inﬂuences on cardiovascular
and renal development. Eur J Epidemiol. 2010;25(10):677–92.
11. Waller K, Kujala UM, Rantanen T, Kauppinen M, Silventoinen
K, Koskenvuo M, et al. Physical activity, morbidity and mor-
tality in twins: a 24-year prospective follow-up. Eur J Epidem-
iol. 2010;25(10):731–9.
12. Alatupa S, Pulkki-Raback L, Hintsanen M, Ravaja N, Raitakari
OT, Telama R, et al. School performance as a predictor of
adulthood obesity: a 21-year follow-up study. Eur J Epidemiol.
2010;25(4):267–74.
13. Engeland A, Bjorge T, Daltveit AK, Skurtveit S, Vangen S,
Vollset SE, et al. Risk of diabetes after gestational diabetes and
preeclampsia. A registry-based study of 230,000 women in
Norway. Eur J Epidemiol. 2011;26(2):157–63.
14. Durmus B, Ay L, Hokken-Koelega AC, Raat H, Hofman A,
Steegers EA, et al. Maternal smoking during pregnancy and
subcutaneous fat mass in early childhood. The Generation R
Study. Eur J Epidemiol. 2011;26(4):295–304.
15. Beyerlein A, Ruckinger S, Toschke AM. Schaffrath Rosario A,
von Kries R. Is low birth weight in the causal pathway of the
association between maternal smoking in pregnancy and higher
BMI in the offspring? Eur J Epidemiol. 2011;26(5):413–20.
16. Pedersen GS, Mortensen LH, Andersen AM. Ethnic variations in
mortality in pre-school children in Denmark, 1973–2004. Eur J
Epidemiol. 2011;26(7):527–36.
17. Rours GI, Duijts L, Moll HA, Arends LR, de Groot R, Jaddoe
VW, et al. Chlamydia trachomatis infection during pregnancy
associated with preterm delivery: a population-based prospec-
tive cohort study. Eur J Epidemiol. 2011;26(6):493–502.
18. Cnattingius S, Svensson T, Granath F, Iliadou A. Maternal
smoking during pregnancy and risks of suicidal acts in young
offspring. Eur J Epidemiol. 2011;26(6):485–92.
19. LaboutJA,DuijtsL,LebonA,deGrootR,HofmanA,JaddoeVV,
etal.Riskfactorsforotitismediainchildrenwithspecialemphasis
EPIGENETICS 
RESPIRATORY DISEASES  
IN ADULTHOOD 
GENETIC SUSCEPTIBILIBY 
ORMDL3, GST, GSDM, ADAM33, MTHFR, IL6R, 
11q13.5
ASTHMA  
IN CHILDHOOD 
GROWTH 
Fetal growth patterns 
Restricted, accelerated 
Birth outcomes 
Low birth weight, preterm birth 
Infant growth patterns 
Restricted, accelerated 
ENVIRONMENTAL FACTORS 
Fetal exposures 
Smoking, diet (folate, vitamin B12, D and E) 
Infant’s exposures 
Diet (breastfeeding, vitamin D), 
respiratory infectious diseases, acetaminophen 
Fig. 1 Pathways leading from adverse fetal and infant exposures to growth adaptations and respiratory health outcomes
Fetal and infant origins of asthma 9
123on the role of colonization with bacterial airway pathogens:
the Generation R Study. Eur J Epidemiol. 2011;26(1):
61–6.
20. Morseth B, Emaus N, Wilsgaard T, Jacobsen BK, Jorgensen L.
Leisure time physical activity in adulthood is positively asso-
ciated with bone mineral density 22 years later. The Tromso
study. Eur J Epidemiol. 2010;25(5):325–31.
21. Greenwood DC, Alwan N, Boylan S, Cade JE, Charvill J,
Chipps KC, et al. Caffeine intake during pregnancy, late mis-
carriage and stillbirth. Eur J Epidemiol. 2010;25(4):275–80.
22. Ghasemi A, Zahediasl S, Azizi F. Nitric oxide and clustering of
metabolic syndrome components in pediatrics. Eur J Epidemiol.
2010;25(1):45–53.
23. Strand BH, Cooper R, Hardy R, Kuh D, Guralnik J. Lifelong
socioeconomic position and physical performance in midlife:
results from the British 1946 birth cohort. Eur J Epidemiol.
2011;26(6):475–83.
24. Timmermans S, Bonsel GJ, Steegers-Theunissen RP, Macken-
bach JP, Steyerberg EW, Raat H, et al. Individual accumulation
of heterogeneous risks explains perinatal inequalities within
deprived neighbourhoods. Eur J Epidemiol. 2011;26(2):165–80.
25. Borne Y, Engstrom G, Essen B, Sundquist J, Hedblad B.
Country of birth and risk of hospitalization due to heart failure: a
Swedish population-based cohort study. Eur J Epidemiol.
2011;26(4):275–83.
26. Lagiou P, Samoli E, Lipworth L, Lagiou A, Fang F, Rossi M,
et al. Energy intake during pregnancy in relation to offspring
gender by maternal height. Eur J Epidemiol. 2011;26(1):39–44.
27. Gudmundsson P, Andersson S, Gustafson D, Waern M, Ostling
S, Hallstrom T, et al. Depression in Swedish women: relation-
ship to factors at birth. Eur J Epidemiol. 2011;26(1):55–60.
28. Ngo AD, Taylor R, Roberts CL. Paternal exposure to Agent
Orange and spina biﬁda: a meta-analysis. Eur J Epidemiol.
2010;25(1):37–44.
29. Both MI, Overvest MA, Wildhagen MF, Golding J, Wildschut
HI. The association of daily physical activity and birth outcome:
a population-based cohort study. Eur J Epidemiol. 2010;
25(6):421–9.
30. Heys M, Jiang C, Schooling CM, Zhang W, Cheng KK, Lam
TH, et al. Is childhood meat eating associated with better later
adulthood cognition in a developing population? Eur J Epi-
demiol. 2010;25(7):507–16.
31. Sellier E, Surman G, Himmelmann K, Andersen G, Colver A,
Krageloh-Mann I, et al. Trends in prevalence of cerebral palsy in
children born with a birthweight of 2,500 g or over in Europe
from 1980 to 1998. Eur J Epidemiol. 2010;25(9):635–42.
32. Huisman M, Araya R, Lawlor DA, Ormel J, Verhulst FC,
Oldehinkel AJ. Cognitive ability, parental socioeconomic posi-
tion and internalising and externalising problems in adoles-
cence: ﬁndings from two European cohort studies. Eur J
Epidemiol. 2010;25(8):569–80.
33. Reuser M, Willekens FJ, Bonneux L. Higher education delays
and shortens cognitive impairment: a multistate life table anal-
ysis of the US Health and Retirement Study. Eur J Epidemiol.
2011;26(5):395–403.
34. Rours GI, de Krijger RR, Ott A, Willemse HF, de Groot R,
Zimmermann LJ, et al. Chlamydia trachomatis and placental
inﬂammation in early preterm delivery. Eur J Epidemiol.
2011;26(5):421–8.
35. Castello A, Rio I, Sandin-Vazquez M, Bolumar F. Shortening of
gestational length among native-born and immigrants in Spain
(1997–2008). Eur J Epidemiol. 2011;26(7):563–70.
36. Danziger PD, Silverwood R, Koupil I. Fetal growth, early life
circumstances, and risk of suicide in late adulthood. Eur J Ep-
idemiol. 2011;26(7):571–81.
37. Diouf I, Charles MA, Thiebaugeorges O, Forhan A, Kaminski
M, Heude B. Maternal weight change before pregnancy in
relation to birthweight and risks of adverse pregnancy outcomes.
Eur J Epidemiol. 2011;26(10):789–96.
38. Bakker H, Jaddoe VW. Cardiovascular and metabolic inﬂuences
of fetal smoke exposure. Eur J Epidemiol. 2011;26(10):763–70.
39. Tamakoshi K, Yatsuya H, Tamakoshi A. Early age at menarche
associated with increased all-cause mortality. Eur J Epidemiol.
2011;26(10):771–8.
40. Johnson PC, Logue J, McConnachie A, Abu-Rmeileh NM, Hart
C, Upton MN, et al. Intergenerational change and familial
aggregation of body mass index. Eur J Epidemiol. 2011. doi:
10.1007/s10654-011-9639-5.
41. Gaillard R, de Ridder MA, Verburg BO, Witteman JC, Mac-
kenbach JP, Moll HA, et al. Individually customised fetal weight
charts derived from ultrasound measurements: the Generation R
Study. Eur J Epidemiol. 2011;26(12):919–26.
42. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M,
Morgan WJ. Asthma and wheezing in the ﬁrst six years of life.
The Group Health Medical Associates. N Engl J Med.
1995;332(3):133–8.
43. Horak E, Lanigan A, Roberts M, Welsh L, Wilson J, Carlin JB,
et al. Longitudinal study of childhood wheezy bronchitis and
asthma: outcome at age 42. BMJ. 2003;326(7386):422–3.
44. Sears MR, Greene JM, Willan AR, Wiecek EM, Taylor DR,
Flannery EM, et al. A longitudinal, population-based, cohort
study of childhood asthma followed to adulthood. N Engl J Med.
2003;349(15):1414–22.
45. Illi S, von Mutius E, Lau S, Niggemann B, Gruber C, Wahn U,
et al. Perennial allergen sensitisation early in life and chronic
asthma in children: a birth cohort study. Lancet. 2006;368(9537):
763–70.
46. Haland G, Carlsen KC, Sandvik L, Devulapalli CS, Munthe-
Kaas MC, Pettersen M, et al. Reduced lung function at birth and
the risk of asthma at 10 years of age. N Engl J Med.
2006;355(16):1682–9.
47. Stern DA, Morgan WJ, Wright AL, Guerra S, Martinez FD. Poor
airway function in early infancy and lung function by age
22 years: a non-selective longitudinal cohort study. Lancet.
2007;370(9589):758–64.
48. Stern DA, Morgan WJ, Halonen M, Wright AL, Martinez FD.
Wheezing and bronchial hyper-responsiveness in early child-
hood as predictors of newly diagnosed asthma in early adult-
hood: a longitudinal birth-cohort study. Lancet. 2008;372(9643):
1058–64.
49. Duijts L, Jaddoe VW, van der Valk RJ, Henderson AJ, Hofman
A, Raat H, Steegers EA, Moll HA, de Jongste JC. Fetal exposure
to maternal and paternal smoking and the risks of wheezing in
preschool children. The Generation R Study. Chest. 2011. doi:
10.1378/chest.11-0112.
50. Sonnenschein-van der Voort AM, Jaddoe VV, van der Valk RJ,
Willemsen SP, Hofman A, Moll HA, et al. Duration and
exclusiveness of breastfeeding and childhood asthma-related
symptoms. Eur Respir J. 2012;39(1):81–9.
51. von Mutius E. Environmental factors inﬂuencing the develop-
ment and progression of pediatric asthma. J Allergy Clin
Immunol. 2002;109(6 Suppl):S525–32.
52. Lowe A, Braback L, Ekeus C, Hjern A, Forsberg B. Maternal
obesity during pregnancy as a risk for early-life asthma.
J Allergy Clin Immunol. 2011;128(5):1107–9. e1–2.
53. EgeMJ,MayerM,NormandAC,GenuneitJ,CooksonWO,Braun-
FahrlanderC,etal.Exposuretoenvironmentalmicroorganismsand
childhood asthma. N Engl J Med. 2011;364(8):701–9.
54. Beasley RW, Clayton TO, Crane J, Lai CK, Montefort SR,
Mutius E, et al. Acetaminophen use and risk of asthma,
10 L. Duijts
123rhinoconjunctivitis, and eczema in adolescents: International
Study of Asthma and Allergies in Childhood phase three. Am J
Respir Crit Care Med. 2011;183(2):171–8.
55. Bisgaard H, Hermansen MN, Bonnelykke K, Stokholm J, Baty
F, Skytt NL, et al. Association of bacteria and viruses with
wheezy episodes in young children: prospective birth cohort
study. BMJ. 2010;341:c4978.
56. Bisgaard H, Hermansen MN, Buchvald F, Loland L, Halkjaer
LB, Bonnelykke K, et al. Childhood asthma after bacterial
colonization of the airway in neonates. N Engl J Med.
2007;357(15):1487–95.
57. Barker DJ. The intrauterine origins of cardiovascular and
obstructive lung disease in adult life. The Marc Daniels lecture
1990. J R Coll Physicians Lond. 1991;25(2):129–33.
58. Canoy D, Pekkanen J, Elliott P, Pouta A, Laitinen J, Hartikainen
AL, et al. Early growth and adult respiratory function in men
and women followed from the fetal period to adulthood. Thorax.
2007;62(5):396–402.
59. Tennant PW, Gibson GJ, Parker L, Pearce MS. Childhood
respiratory illness and lung function at ages 14 and 50 years:
childhood respiratory illness and lung function. Chest.
2010;137(1):146–55.
60. Hancox RJ, Poulton R, Greene JM, McLachlan CR, Pearce MS,
Sears MR. Associations between birth weight, early childhood
weight gain and adult lung function. Thorax. 2009;64(3):228–32.
61. Lawlor DA, Ebrahim S, Davey Smith V. Association of birth
weight with adult lung function: ﬁndings from the British
Women’s Heart and Health Study and a meta-analysis. Thorax.
2005;60(10):851–8.
62. Caudri D, Wijga A, Gehring U, Smit HA, Brunekreef B,
Kerkhof M, et al. Respiratory symptoms in the ﬁrst 7 years of
life and birth weight at term: the PIAMA Birth Cohort. Am J
Respir Crit Care Med. 2007;175(10):1078–85.
63. Jaddoe VW, Verburg BO, de Ridder MA, Hofman A, Mac-
kenbach JP, Moll HA, et al. Maternal smoking and fetal growth
characteristics in different periods of pregnancy: the Generation
R study. Am J Epidemiol. 2007;165(10):1207–15.
64. Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of
in utero and early-life conditions on adult health and disease.
N Engl J Med. 2008;359(1):61–73.
65. Osler M, Lund R, Kriegbaum M, Andersen AM. The inﬂuence
of birth weight and body mass in early adulthood on early
coronary heart disease risk among Danish men born in 1953. Eur
J Epidemiol. 2009;24(1):57–61.
66. Barker DJ, Godfrey KM, Fall C, Osmond C, Winter PD,
Shaheen SO. Relation of birth weight and childhood respiratory
infection to adult lung function and death from chronic
obstructive airways disease. BMJ. 1991;303(6804):671–5.
67. Shi W, Bellusci S, Warburton D. Lung development and adult
lung diseases. Chest. 2007;132(2):651–6.
68. Aysola RS, Hoffman EA, Gierada D, Wenzel S, Cook-Granroth
J, Tarsi J, et al. Airway remodeling measured by multidetector
CT is increased in severe asthma and correlates with pathology.
Chest. 2008;134(6):1183–91.
69. Castagnaro A, Rastelli A, Chetta A, Marangio E, Tzani P, De
Filippo M, et al. High-resolution computed tomography evalu-
ation of airway distensibility in asthmatic and healthy subjects.
Radiol Med. 2008;113(1):43–55.
70. Grainge CL, Lau LC, Ward JA, Dulay V, Lahiff G, Wilson S,
et al. Effect of bronchoconstriction on airway remodeling in
asthma. N Engl J Med. 2011;364(21):2006–15.
71. van der Gugten A, Korte K, van der Ent K, Uiterwaal C, Verheij
T. Small airway caliber is the most important contributor of
wheezing in healthy unselected newborns. Am J Respir Crit
Care Med. 2011;183(4):553. (Author reply-4).
72. van Oosterhout AJ, Bloksma N. Regulatory T-lymphocytes in
asthma. Eur Respir J. 2005;26(5):918–32.
73. Tang ML, Kemp AS, Thorburn J, Hill DJ. Reduced interferon-
gamma secretion in neonates and subsequent atopy. Lancet.
1994;344(8928):983–5.
74. Sly PD, Holt PG. Role of innate immunity in the development of
allergy and asthma. Curr Opin Allergy Clin Immunol.
2011;11(2):127–31.
75. Gimeno D, Delclos GL, Ferrie JE, De Vogli R, Elovainio M,
Marmot MG, et al. Association of CRP and IL-6 with lung
function in a middle-aged population initially free from self-
reported respiratory problems: the Whitehall II study. Eur J
Epidemiol. 2011;26(2):135–44.
76. Inskip HM, Godfrey KM, Robinson SM, Law CM, Barker DJ,
Cooper C, et al. Cohort proﬁle: the Southampton women’s
survey. Int J Epidemiol. 2006;35(1):42–8.
77. Jaddoe VW, van Duijn CM, van der Heijden AJ, Mackenbach JP,
Moll HA, Steegers EA, et al. The Generation R Study: design and
cohort update 2010. Eur J Epidemiol. 2010;25(11):823–41.
78. Pike KC, Crozier SR, Lucas JS, Inskip HM, Robinson S, Roberts
G,etal.Patternsoffetalandinfantgrowtharerelatedtoatopyand
wheezing disorders at age 3 years. Thorax. 2010;65(12):
1099–106.
79. Turner S, Prabhu N, Danielan P, McNeill G, Craig L, Allan C,
etal.First-andsecond-trimesterfetalsizeandasthmaoutcomesat
age 10 years. Am J Respir Crit Care Med. 2011;184(4):407–13.
80. van der Gugten AC, Koopman M, Evelein AM, Verheij TJ,
Uiterwaal CS, van der Ent CK. Rapid early weight gain is
associated with wheeze and reduced lung function in childhood.
Eur Respir J. 2012;39(2):403–10.
81. Sonnenschein-van der Voort AM, Jaddoe VW, Raat H, Moll
HA, Hofman A, de Jongste JC, et al. Fetal and Infant Growth
and Asthma Symptoms in Preschool Children. The Generation R
Study. Am J Respir Crit Care Med. 2012. doi:10.1164/rccm.
201107-1266OC.
82. Jaakkola JJ, Ahmed P, Ieromnimon A, Goepfert P, Laiou E,
Quansah R, et al. Preterm delivery and asthma: a systematic
review and meta-analysis. J Allergy Clin Immunol. 2006;118(4):
823–30.
83. Gessner BD, Chimonas MA. Asthma is associated with preterm
birth but not with small for gestational age status among a
population-based cohort of Medicaid-enrolled chil-
dren\10 years of age. Thorax. 2007;62(3):231–6.
84. Kumar R, Yu Y, Story RE, Pongracic JA, Gupta R, Pearson C,
et al. Prematurity, chorioamnionitis, and the development of
recurrent wheezing: a prospective birth cohort study. J Allergy
Clin Immunol. 2008;121(4):878–84. (e6).
85. Abe K, Shapiro-Mendoza CK, Hall LR, Satten GA. Late preterm
birth and risk of developing asthma. J Pediatr. 2010;157(1):
74–8.
86. Fawke J, Lum S, Kirkby J, Hennessy E, Marlow N, Rowell V,
et al. Lung function and respiratory symptoms at 11 years in
children born extremely preterm: the EPICure study. Am J
Respir Crit Care Med. 2010;182(2):237–45.
87. Crump C, Winkleby MA, Sundquist J, Sundquist K. Risk of
asthma in young adults who were born preterm: a Swedish
national cohort study. Pediatrics. 2011;127(4):e913–20.
88. Kotecha SJ, Watkins WJ, Paranjothy S, Dunstan FD, Henderson
AJ, Kotecha S. Effect of late preterm birth on longitudinal lung
spirometry in school age children and adolescents. Thorax.
2012;67(1):54–61.
89. Siltanen M, Wehkalampi K, Hovi P, Eriksson JG, Strang-Kar-
lsson S, Jarvenpaa AL, et al. Preterm birth reduces the incidence
of atopy in adulthood. J Allergy Clin Immunol. 2011;127(4):
935–42.
Fetal and infant origins of asthma 11
12390. Broughton S, Thomas MR, Marston L, Calvert SA, Marlow N,
Peacock JL, et al. Very prematurely born infants wheezing at
follow-up: lung function and risk factors. Arch Dis Child.
2007;92(9):776–80.
91. Hallman M, Marttila R, Pertile R, Ojaniemi M, Haataja R.
Genes and environment in common neonatal lung disease.
Neonatology. 2007;91(4):298–302.
92. Baraldi E, Filippone M. Chronic lung disease after premature
birth. N Engl J Med. 2007;357(19):1946–55.
93. Lux AL, Henderson AJ, Pocock SJ. Wheeze associated with
prenatal tobacco smoke exposure: a prospective, longitudinal
study. ALSPAC study team. Arch Dis Child. 2000;83(4):
307–12.
94. Haberg SE, Stigum H, Nystad W, Nafstad P. Effects of pre- and
postnatal exposure to parental smoking on early childhood
respiratory health. Am J Epidemiol. 2007;166(6):679–86.
95. Lannero E, Wickman M, Pershagen G, Nordvall L. Maternal
smoking during pregnancy increases the risk of recurrent
wheezing during the ﬁrst years of life (BAMSE). Respir Res.
2006;7:3.
96. Magnusson LL, Olesen AB, Wennborg H, Olsen J. Wheezing,
asthma, hayfever, and atopic eczema in childhood following
exposure to tobacco smoke in fetal life. Clin Exp Allergy.
2005;35(12):1550–6.
97. Gilliland FD, Berhane K, Li YF, Rappaport EB, Peters JM.
Effects of early onset asthma and in utero exposure to maternal
smoking on childhood lung function. Am J Respir Crit Care
Med. 2003;167(6):917–24.
98. Stein RT, Holberg CJ, Sherrill D, Wright AL, Morgan WJ,
Taussig L, et al. Inﬂuence of parental smoking on respiratory
symptoms during the ﬁrst decade of life: the Tucson Children’s
Respiratory Study. Am J Epidemiol. 1999;149(11):1030–7.
99. Prabhu N, Smith N, Campbell D, Craig LC, Seaton A, Helms PJ,
et al. First trimester maternal tobacco smoking habits and fetal
growth. Thorax. 2010;65(3):235–40.
100. Davey Smith G, Leary S, Ness A, Lawlor DA. Challenges and
novel approaches in the epidemiological study of early life
inﬂuences on later disease. Adv Exp Med Biol. 2009;646:1–14.
101. Brion MJ, Leary SD, Smith GD, Ness AR. Similar associations
of parental prenatal smoking suggest child blood pressure is not
inﬂuenced by intrauterine effects. Hypertension. 2007;49(6):
1422–8.
102. Breton CV, Byun HM, Wang X, Salam MT, Siegmund K,
Gilliland FD. DNA methylation in the arginase-nitric oxide
synthase pathway is associated with exhaled nitric oxide in
children with asthma. Am J Respir Crit Care Med. 2011;184(2):
191–7.
103. Breton CV, Byun HM, Wenten M, Pan F, Yang A, Gilliland FD.
Prenatal tobaccosmokeexposureaffectsglobalandgene-speciﬁc
DNA methylation. Am J Respir Crit Care Med. 2009;180(5):
462–7.
104. Patel SP, Rodriguez A, Little MP, Elliott P, Pekkanen J, Har-
tikainen AL, et al. Associations between pre-pregnancy obesity
and asthma symptoms in adolescents. J Epidemiol Commun
Health. 2011. doi:10.1136/jech.2011.133777.
105. Lopuhaa CE, Roseboom TJ, Osmond C, Barker DJ, Ravelli AC,
Bleker OP, et al. Atopy, lung function, and obstructive airways dis-
ease after prenatal exposure to famine. Thorax. 2000;55(7):555–61.
106. Schachter LM, Salome CM, Peat JK, Woolcock AJ. Obesity is a
risk for asthma and wheeze but not airway hyperresponsiveness.
Thorax. 2001;56(1):4–8.
107. Lowe A, Braback L, Ekeus C, Hjern A, Forsberg B. Maternal
obesity during pregnancy as a risk for early-life asthma.
J Allergy Clin Immunol. 2011;128(5):1107–9. (e1–e2).
108. Ay L, Kruithof CJ, Bakker R, Steegers EA, Witteman JC, Moll
HA, et al. Maternal anthropometrics are associated with fetal
size in different periods of pregnancy and at birth. The Gener-
ation R Study. BJOG. 2009;116(7):953–63.
109. Shaheen SO. Prenatal nutrition and asthma: hope or hype?
Thorax. 2008;63(6):483–5.
110. Whitrow MJ, Moore VM, Rumbold AR, Davies MJ. Effect of
supplemental folic acid in pregnancy on childhood asthma: a pro-
spective birth cohort study. Am J Epidemiol. 2009;170(12):
1486–93.
111. Haberg SE, London SJ, Stigum H, Nafstad P, Nystad W. Folic
acid supplements in pregnancy and early childhood respiratory
health. Arch Dis Child. 2009;94(3):180–4.
112. Turner SW, Campbell D, Smith N, Craig LC, McNeill G, Forbes
SH, et al. Associations between fetal size, maternal {alpha}-
tocopherol and childhood asthma. Thorax. 2010;65(5):391–7.
113. Shaheen SO, Northstone K, Newson RB, Emmett PM, Sherriff
A, Henderson AJ. Dietary patterns in pregnancy and respiratory
and atopic outcomes in childhood. Thorax. 2009;64(5):411–7.
114. Scholtens S, Wijga AH, Brunekreef B, Kerkhof M, Postma DS,
Oldenwening M, et al. Maternal overweight before pregnancy
and asthma in offspring followed for 8 years. Int J Obes (Lond).
2010;34(4):606–13.
115. Nagel G, Weinmayr G, Kleiner A, Garcia-Marcos L, Strachan
DP. Effect of diet on asthma and allergic sensitisation in the
International Study on Allergies and Asthma in Childhood
(ISAAC) phase two. Thorax. 2010;65(6):516–22.
116. Granell R, Heron J, Lewis S, Davey Smith G, Sterne JA, Hen-
derson J. The association between mother and child MTHFR
C677T polymorphisms, dietary folate intake and childhood
atopy in a population-based, longitudinal birth cohort. Clin Exp
Allergy. 2008;38(2):320–8.
117. Heppe DH, Steegers EA, Timmermans S, Breeijen H, Tiemeier
H, Hofman A, et al. Maternal ﬁsh consumption, fetal growth and
the risks of neonatal complications: the Generation R Study. Br J
Nutr. 2011;105(6):938–49.
118. Stein AD, Ravelli AC, Lumey LH. Famine, third-trimester
pregnancy weight gain, and intrauterine growth: the Dutch
Famine Birth Cohort Study. Hum Biol. 1995;67(1):135–50.
119. Miyake Y, Okubo H, Sasaki S, Tanaka K, Hirota Y. Maternal
dietary patterns during pregnancy and risk of wheeze and
eczema in Japanese infants aged 16–24 months: the Osaka
Maternal and Child Health Study. Pediatr Allergy Immunol.
2011;22(7):734–41.
120. Heijmans BT, Tobi EW, Stein AD, Putter H, Blauw GJ, Susser
ES, et al. Persistent epigenetic differences associated with pre-
natal exposure to famine in humans. Proc Natl Acad Sci USA.
2008;105(44):17046–9.
121. Tobi EW, Heijmans BT, Kremer D, Putter H, Delemarre-van de
Waal HA, Finken MJ, et al. DNA methylation of IGF2, GNA-
SAS, INSIGF and LEP and being born small for gestational age.
Epigenetics. 2011;6(2):171–6.
122. Steegers-Theunissen RP, Obermann-Borst SA, Kremer D,
Lindemans J, Siebel C, Steegers EA, et al. Periconceptional
maternal folic acid use of 400 microg per day is related to
increased methylation of the IGF2 gene in the very young child.
PLoS One. 2009;4(11):e7845.
123. Camargo CA Jr, Rifas-Shiman SL, Litonjua AA, Rich-Edwards
JW, Weiss ST, Gold DR, et al. Maternal intake of vitamin D
during pregnancy and risk of recurrent wheeze in children at 3 y
of age. Am J Clin Nutr. 2007;85(3):788–95.
124. Devereux G, Litonjua AA, Turner SW, Craig LC, McNeill G,
Martindale S, et al. Maternal vitamin D intake during pregnancy
and early childhood wheezing. Am J ClinNutr. 2007;85(3):853–9.
125. Miyake Y, Sasaki S, Tanaka K, Hirota Y. Maternal B vitamin
intake during pregnancy and wheeze and eczema in Japanese
infants aged 16–24 months: the Osaka Maternal and Child
Health Study. Pediatr Allergy Immunol. 2011;22(1 Pt 1):69–74.
12 L. Duijts
123126. Erkkola M, Kaila M, Nwaru BI, Kronberg-Kippila C, Ahonen S,
Nevalainen J, et al. Maternal vitamin D intake during pregnancy
is inversely associated with asthma and allergic rhinitis in
5-year-old children. Clin Exp Allergy. 2009;39(6):875–82.
127. Sundar IK, Rahman I. Vitamin d and susceptibility of chronic
lung diseases: role of epigenetics. Front Pharmacol. 2011;2:50.
128. DurmusB,van Rossem L,Duijts L, ArendsLR, Raat H,Moll HA,
etal.Breast-feedingandgrowthinchildrenuntiltheageof3 years:
the Generation R Study. Br J Nutr. 2011;105(11):1704–11.
129. Kramer MS, Matush L, Vanilovich I, Platt R, Bogdanovich N,
Sevkovskaya Z, et al. Effect of prolonged and exclusive breast
feeding on risk of allergy and asthma: cluster randomised trial.
BMJ. 2007 Oct 20;335(7624):815.
130. Sears MR, Greene JM, Willan AR, Taylor DR, Flannery EM,
Cowan JO, et al. Long-term relation between breastfeeding and
development of atopy and asthma in children and young adults:
a longitudinal study. Lancet. 2002;360(9337):901–7.
131. Elliott L, Henderson J, Northstone K, Chiu GY, Dunson D,
London SJ. Prospective study of breast-feeding in relation to
wheeze, atopy, and bronchial hyperresponsiveness in the Avon
Longitudinal Study of Parents and Children (ALSPAC).
J Allergy Clin Immunol. 2008;122(1):49–54. (e1–e3).
132. Fisk CM, Crozier SR, Inskip HM, Godfrey KM, Cooper C,
Roberts GC, et al. Breastfeeding and reported morbidity during
infancy: ﬁndings from the Southampton Women’s Survey.
Matern Child Nutr. 2011;7(1):61–70.
133. Friedman NJ, Zeiger RS. The role of breast-feeding in the
development of allergies and asthma. J Allergy Clin Immunol.
2005;115(6):1238–48.
134. Newburg DS. Neonatal protection by an innate immune system
of human milk consisting of oligosaccharides and glycans.
J Anim Sci. 2009;87(13 Suppl):26–34.
135. Hoppu U, Kalliomaki M, Laiho K, Isolauri E. Breast milk–
immunomodulatory signals against allergic diseases. Allergy.
2001;56(Suppl 67):23–6.
136. Scholtens S, Wijga AH, Brunekreef B, Kerkhof M, Hoekstra
MO, Gerritsen J, et al. Breast feeding, parental allergy and
asthma in children followed for 8 years. The PIAMA birth
cohort study. Thorax. 2009;64(7):604–9.
137. Rothenbacher D, Weyermann M, Beermann C, Brenner H.
Breastfeeding, soluble CD14 concentration in breast milk and
risk of atopic dermatitis and asthma in early childhood: birth
cohort study. Clin Exp Allergy. 2005;35(8):1014–21.
138. Wright AL, Holberg CJ, Taussig LM, Martinez FD. Factors
inﬂuencing the relation of infant feeding to asthma and recurrent
wheeze in childhood. Thorax. 2001;56(3):192–7.
139. Ball TM, Castro-Rodriguez JA, Grifﬁth KA, Holberg CJ, Mar-
tinez FD, Wright AL. Siblings, day-care attendance, and the risk
of asthma and wheezing during childhood. N Engl J Med.
2000;343(8):538–43.
140. Mook-Kanamori DO, Steegers EA, Uitterlinden AG, Moll HA,
van Duijn CM, Hofman A, et al. Breast-feeding modiﬁes the
association of PPARgamma2 polymorphism Pro12Ala with
growth in early life: the Generation R Study. Diabetes. 2009;
58(4):992–8.
141. Riedler J, Braun-Fahrlander C, Eder W, Schreuer M, Waser M,
Maisch S, et al. Exposure to farming in early life and devel-
opment of asthma and allergy: a cross-sectional survey. Lancet.
2001;358(9288):1129–33.
142. Friedlander SL, Jackson DJ, Gangnon RE, Evans MD, Li Z,
Roberg KA, et al. Viral infections, cytokine dysregulation and
the origins of childhood asthma and allergic diseases. Pediatr
Infect Dis J. 2005;24(11 Suppl):S170–6. (discussion S4–S5).
143. Shaheen SO, Barker DJ, Holgate ST. Do lower respiratory
tract infections in early childhood cause chronic obstructive
pulmonary disease? Am J Respir Crit Care Med. 1995;151(5):
1649–51. (discussion 51–52).
144. Schnabel E, Heinrich J, Group LS. Respiratory tract infections
and not paracetamol medication during infancy are associated
with asthma development in childhood. J Allergy Clin Immunol.
2010;126(5):1071–3.
145. Lebon A, Labout JA, Verbrugh HA, Jaddoe VW, Hofman A,
van Wamel WJ, et al. Role of Staphylococcus aureus nasal
colonization in atopic dermatitis in infants: the Generation R
Study. Arch Pediatr Adolesc Med. 2009;163(8):745–9.
146. Lowe AJ, Carlin JB, Bennett CM, Hosking CS, Allen KJ,
Robertson CF, et al. Paracetamol use in early life and asthma:
prospective birth cohort study. BMJ. 2010;341:c4616.
147. Shaheen SO, Newson RB, Ring SM, Rose-Zerilli MJ, Holloway
JW, Henderson AJ. Prenatal and infant acetaminophen exposure,
antioxidant gene polymorphisms, and childhood asthma.
J Allergy Clin Immunol. 2010;126(6):1141–8. (e7).
148. Shaheen SO, Newson RB, Sherriff A, Henderson AJ, Heron JE,
Burney PG, et al. Paracetamol use in pregnancy and wheezing in
early childhood. Thorax. 2002;57(11):958–63.
149. Shaheen SO, Newson RB, Henderson AJ, Headley JE, Stratton
FD, Jones RW, et al. Prenatal paracetamol exposure and risk of
asthma and elevated immunoglobulin E in childhood. Clin Exp
Allergy. 2005;35(1):18–25.
150. Shaheen SO, Newson RB, Smith GD, Henderson AJ. Prenatal
paracetamol exposure and asthma: further evidence against
confounding. Int J Epidemiol. 2010;39(3):790–4.
151. McBride JT. The association of acetaminophen and asthma
prevalence and severity. Pediatrics. 2011;128(6):1181–5.
152. Ober C, Hoffjan S. Asthma genetics 2006: the long and winding
road to gene discovery. Genes Immun. 2006;7(2):95–100.
153. Hall IP, Blakey JD, Al Balushi KA, Wheatley A, Sayers I,
Pembrey ME, et al. Beta2-adrenoceptor polymorphisms and
asthma from childhood to middle age in the British 1958 birth
cohort: a genetic association study. Lancet. 2006;368(9537):
771–9.
154. Noguchi E, Sakamoto H, Hirota T, Ochiai K, Imoto Y, Sakashita
M, et al. Genome-Wide Association Study identiﬁes HLA-DP as
a susceptibility gene for pediatric asthma in Asian populations.
PLoS Genet. 2011;7(7):e1002170.
155. Hancock DB, Romieu I, Shi M, Sienra-Monge JJ, Wu H, Chiu
GY, et al. Genome-wide association study implicates chromo-
some 9q21.31 as a susceptibility locus for asthma in mexican
children. PLoS Genet. 2009;5(8):e1000623.
156. Mexico City Childhood Asthma S, Torgerson DG, Ampleford
EJ, Chiu GY, Gauderman WJ, Gignoux CR, et al. Meta-analysis
of genome-wide association studies of asthma in ethnically
diverse North American populations. Nat Genet. 2011;43(9):
887–92.
157. Hirota T, Takahashi A, Kubo M, Tsunoda T, Tomita K, Doi S,
et al. Genome-wide association study identiﬁes three new sus-
ceptibility loci for adult asthma in the Japanese population. Nat
Genet. 2011;43(9):893–6.
158. Moffatt MF, Gut IG, Demenais F, Strachan DP, Bouzigon E,
Heath S, et al. A large-scale, consortium-based genomewide
association study of asthma. N Engl J Med. 2010;363(13):
1211–21.
159. Sleiman PM, Flory J, Imielinski M, Bradﬁeld JP, Annaiah K,
Willis-Owen SA, et al. Variants of DENND1B associated with
asthma in children. N Engl J Med. 2010;362(1):36–44.
160. Ferreira MA, Matheson MC, Duffy DL, Marks GB, Hui J, Le
Souef P, et al. Identiﬁcation of IL6R and chromosome 11q13.5
as risk loci for asthma. Lancet. 2011;378(9795):1006–14.
161. Freathy RM, Mook-Kanamori DO, Sovio U, Prokopenko I,
Timpson NJ, Berry DJ, et al. Variants in ADCY5 and near
Fetal and infant origins of asthma 13
123CCNL1 are associated with fetal growth and birth weight. Nat
Genet. 2010;42(5):430–5.
162. Bouzigon E, Corda E, Aschard H, Dizier MH, Boland A,
Bousquet J, et al. Effect of 17q21 variants and smoking exposure
in early-onset asthma. N Engl J Med. 2008;359(19):1985–94.
163. Murdzoska J, Devadason SG, Khoo SK, Landau LI, Young S,
Goldblatt J, et al. In utero smoke exposure and role of maternal
and infant glutathione s-transferase genes on airway respon-
siveness and lung function in infancy. Am J Respir Crit Care
Med. 2010;181(1):64–71.
164. Flory JH, Sleiman PM, Christie JD, Annaiah K, Bradﬁeld J, Kim
CE, et al. 17q12-21 variants interact with smoke exposure as a
risk factor for pediatric asthma but are equally associated with
early-onset versus late-onset asthma in North Americans of
European ancestry. J Allergy Clin Immunol. 2009;124(3):605–7.
165. Meyers DA, Postma DS, Stine OC, Koppelman GH, Ampleford
EJ, Jongepier H, et al. Genome screen for asthma and bronchial
hyperresponsiveness: interactions with passive smoke exposure.
J Allergy Clin Immunol. 2005;115(6):1169–75.
166. Panasevich S, Lindgren C, Kere J, Wickman M, Pershagen G,
Nyberg F, et al. Interaction between early maternal smoking and
variants in TNF and GSTP1 in childhood wheezing. Clin Exp
Allergy. 2010;40(3):458–67.
167. Schultz EN, Devadason SG, Khoo SK, Zhang G, Bizzintino JA,
Martin AC, et al. The role of GSTP1 polymorphisms and
tobacco smoke exposure in children with acute asthma.
J Asthma. 2010;47(9):1049–56.
168. Minelli C, Granell R, Newson R, Rose-Zerilli MJ, Torrent M,
Ring SM, et al. Glutathione-S-transferase genes and asthma
phenotypes: a Human Genome Epidemiology (HuGE) system-
atic review and meta-analysis including unpublished data. Int J
Epidemiol. 2010;39(2):539–62.
14 L. Duijts
123